Waterfield Advisors Equities Head Views Peak Macro Concerns as Potentially Behind Advocates Staggered Approach Boston Scientific Shares Decline After Reiterating FullYear Growth Outlook Secondary Market for Anthropic Shares Heats Up Amid Concerns of Potential Fraud Swiss Franc and Japanese Yen Strengthen as DeepSeek AI News Spurs SafeHaven Demand Silicon Valley Turns to Boring Businesses AI and Dealmaking Reshape Unsexy Industries US Jobless Claims Remain at Low Levels Signaling Labor Market Resilience Brilliant Earth Group Inc BRLT Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Operational Progress Pegasystems Inc PEGA Q1 2026 Earnings EPS Misses Estimates by 32 Stock Edges Higher PASG Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction Titan Mining Q1 2026 Earnings Strong EPS Surprise Despite Absent Revenue Data HIG Q1 2026 Earnings EPS Misses Estimates Amid Elevated Catastrophe Losses AGNCO Q1 2026 Earnings Strong EPS Surprise of 145 Drives Positive Stock Movement A SPAC III Acquisition Corp Unit ASPCU Rises 378 as Momentum Builds Toward Key Resistance C1 Fund Inc CFND Slides 14 as Selling Pressure Intensifies Near Key Support Advantage Solutions ADV Plunges Over 9 Key Support Levels in Focus 1RT Acquisition Corp Units ONCHU Holds Steady at 1032 Amid Quiet Trading LPA Faces Significant Pullback Logistic Properties of the Americas Declines 549 IMMX Q1 2026 Earnings Smallerthanexpected loss drives positive sentiment CLOV Q1 2026 Earnings EPS Surges Past Estimates Driving Stock Higher FOXF Q1 2026 Earnings Strong EPS Beat Despite Market Headwinds STG Q3 2025 Earnings Reported EPS of 932 Stock Declines 95 Amid Limited Disclosures Janus International Group Inc JBI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Weak Results SYNA Q1 2026 Earnings EPS Surpasses Estimates as Operating Disciplines Shine Minnesota Enacts Landmark Ban on Prediction Markets Making Operation a Felony Kewaunee Scientific KEQU Q1 2026 Earnings Earnings Per Share of 028 as Stock Edges Lower Esperion Therapeutics Holds Steady Near Support Testing Key Resistance Zone